The only way the U.S. could get away with this much debt issuance would be if the Fed printed trillions of dollars and used it to buy Treasuries.

Reopening the government will avert a recession that may have come to pass in the event of a prolonged shutdown lasting weeks or months longer, according to economic analysts. 

Technical analysis on the stock chart for LMND.

FCOJ futures were lower yesterday and the trends are turning mixed on the daily reports.

Ebay finishes a projected correction and resumes its bullish trend from a technical perspective and by Elliott Wave model.

The Dow Jones Industrial Average is up nearly 350 points this afternoon, as a House vote slated for later today to end the government shutdown injects optimism into the market.

High beta stocks, shares with relatively high levels of return volatility, are leading the field by a wide margin, based on a set of ETFs.

PharmaEssentia Corporation develops and distributes drugs to treat hepatitis, chronic myeloid leukemia, essential thrombocythemia, myeloid fibrosis, polycythemia vera, hepatitis, and cancer.

IBM stock gained after it introduced Quantum Nighthawk, a new 120-qubit processor that marks its most advanced quantum chip so far.

As oil falters and clean energy faces growing pains, natural gas is emerging as the bright spot—an energy source that is both pragmatic and profitable.

AMD hosted its Investor Day yesterday, where executives outlined an ambitious roadmap focused on capitalizing on the rapidly expanding AI and compute markets. If the chipmaker hits its mark, AMD investors could earn rich rewards.

After opening the day higher, the benchmark indices continued their upward momentum, ended the session in green.

Ituran has paid variable quarterly dividends since June 2012. The current forward-looking annual dividend of $2.00 yields 5.33% as of Tuesday’s share price.

The AUD/USD outlook shows the pair edging lower amid a firm greenback.

The Dow was in focus for many traders after hitting a new peak above 48,000.

Gold remains bullish as safe haven demand intensifies due to the ongoing U.S. government shutdown, with support near $4050 and resistance at $4190–$4220.

AbbVie is experiencing increased momentum as analysts raise targets, positioning the stock near its 52-week high amidst strong technical indicators and favorable market sentiment.

Pfizer’s comeback, Newmont’s resilience, and Utz’s growth positioning make them compelling candidates for year-end gains.

The CPI report for October may be cancelled.

The Euro eases to 1.1575 but remains trading within the previous day's range.